Asian high yield outlook Ross Dilkes: China's recovery a boon for Asian high yield bonds

China makes up a significant allocation in the Asian high yield universe and its recovery will help the asset class. Ross Dilkes, PM for Asian high yield bonds also adds that China property is an attractive segment.

17 Jul 2020

The article first appeared in The Edge Singapore.

China’s steady path to recovery will help Asian high yield bonds

Notably, China, the first country to implement a lockdown was also the first country to resume economic activity and we now see strong signs of a gradual recovery.

On the back of that, Asian high yield bonds are poised to rebound as well.

Capture China’s recovery

And get >6% payout p.a.1
With UBS (Lux) Bond SICAV - Asian High Yield (USD)

At the start of this year, Asian high yield bonds were one of the asset classes favoured by UBS Asset Management (UBS-AM) to outperform. Their valuations did not look overly stretched and fundamentals were firm. In fact, the US and China had just signed Phase One of a trade deal to end a costly trade war.

Nevertheless, the pandemic took the world by storm, sending financial markets into a tailspin. Asian high yield bonds were not immune to the market turmoil too. To curb the spread of Covid-19, many countries initiated strict lockdown measures that inevitably forced the temporary shutdown of many industries, bringing economic activity to a halt.

Now as the spread of Covid-19 appears to come under control across some countries in Asia, economies are gradually starting to reopen. Notably, China, the first country to implement a lockdown was also the first country to resume economic activity and we now see strong signs of a gradual recovery.

On the back of that, Asian high yield bonds are poised to rebound as well. Within the Asian High Yield universe, China makes up for a significant share of the market with around 47%.

You poll, we donate

With every poll, we’re donating $5 to help a child break the poverty cycle

Additionally, Asian bond yields are currently close to levels last seen during the global financial crisis in 2008, implying that valuations are attractive. This presents a good entry opportunity for investors.

Ross Dilkes, who manages the UBS Asian high yield portfolio, reckons that China should be on a steady path to recovery. “We think China is in a better place now as it has successfully contained the spread of the virus. Compared to the rest of the world, we think Asia, particularly China, stands to recover the fastest,” he says.

Dilkes’ optimism is underpinned by several factors. For one, the normalisation of economic activity to about 80% is “pretty dramatic”, he says. “That gives a lot of comfort to the outlook — for the rest of the year and beyond,” he says.

Secondly, China still has ample ammunition to spur its economy — either through fiscal spending or monetary policy. This was the result of the country’s measured policy response in the last two years.

We haven’t seen a huge government push on fiscal spending — the type of announcements made in 2008. So, China has room to take action to support its economy.

Moreover, China’s banking and financial system has grown robust over the years. Companies now have access to various sources of liquidity for working capital purposes and to meet financial obligations. This is unlike other emerging markets (EM), such as Indonesia and India, where avenues to raise funds are more challenging. “China’s got the ability to support private companies and make sure [there is no] significant pick up in refinancing concerns, which is quite unique compared to the rest of the EM world,” says Dilkes.

Asian high yield outlook Opportunities in China real estate

So, where in China does Dilkes see opportunities? The property sector, particularly the residential segment, looks attractive, he says. Demand for housing has returned and this has pushed up prices, he points out. “As most of the players are deriving a significant portion of their revenue from the residential market, the fund stands to benefit,” he says.

The fund, however, is avoiding the commercial segment of the property market. Dilkes notes commercial properties are facing pressure on rental reversions considering the impact brought by the pandemic.
The fund is also avoiding the office segment. Dilkes says people are increasingly questioning the future of workplaces in the next five to 10 years, given that work from home arrangements could take root.
“There’s probably more longer term question marks, if not stress around the office space,” he says.

Asian high yield outlook Bond defaults in Asian high yield have not picked up materially

Crucially, bond defaults in China and Asia overall have not picked up materially, according to Dilkes. He reiterates that China’s fundamentals remain “pretty sound”. “In stressed situations like this, it’s not just necessarily about the business model but about liquidity and financing,” he says.

Overall, Dilkes is confident that the UBS Asian high yield strategy could do well on the back of China’s recovery.

Despite the challenges that the world has faced in the last few months, when we look at Asian high yield bonds, the forward-looking trends look attractive. And now is an attractive entry point for investors as yields are at levels last seen only during the Global Financial Crisis.

Ross Dilkes

Portfolio Manager
UBS Asian high yield strategy

Tap the opportunity in Asian high yield bonds

1 Source: UBS Asset Management, as of 31 Jul 2020. Past payout yields and payments do not represent future payout yields and payment. Payout yield does not equal to total return and is not guaranteed. Equivalent yield is derived from simple arithmetic calculation where the dividend is divided by the NAV, and annualised thereafter. Please use this for reference only. This share class which pays distribution may distribute not only investment income, but also realised and unrealised capital gains or capital. Where capital is distributed, this will result in a corresponding reduction in the value of Shares, and a reduction in the potential for long-term capital growth.

Ross Dilkes

Portfolio Manager
UBS Asian high yield strategy

Ross Dilkes is a portfolio manager with the Pan Asia fixed income team and has strategy responsibility for selection of corporate issues in Pan Asian portfolios. Ross also contributes to the development of sector and industry allocation strategies across Pan Asia portfolios.

Ross joined UBS Asset Management in December 2005 as a credit analyst within the European Credit Research team based in London.

Ross transferred to the APAC Fixed Income team located in Hong Kong in 2009 where he was responsible for credit research coverage of APAC investment grade and high yield issuers.

Prior to joining UBS Asset Management, Ross worked for Debtwire in London as an analyst covering high yield, distressed debt, leveraged finance and restructuring situations.

Subscribe now

Perspectives matter. Tune in to our insights.

More insights

Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE (collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset